Cardiotropin-1 and myocardial strain change heterogeneously in cardiomyopathy

D Dean Potter1, Philip A Araoz, Leong L Ng

  • 1Division of Cardiovascular Surgery, University of Leicester, Leicester, United Kingdom.

Insights

Heart failure pacing causes uneven changes in cardiotrophin-1 (CT-1) and wall motion, particularly near the pacemaker. These regional differences in CT-1 may explain myocyte hypertrophy and maintained function in these areas.

Area of Science:

  • Cardiovascular Research
  • Biomedical Engineering
  • Cardiac Electrophysiology

Background:

  • Heart failure pacing induces heterogeneous changes in myocardial wall stress and myocyte diameter.
  • Cardiotrophin-1 (CT-1) is a cytokine implicated in left ventricular (LV) remodeling.
  • Understanding regional variations in CT-1 and LV strain is crucial for managing heart failure.

Purpose of the Study:

  • To measure regional changes in cardiotrophin-1 (CT-1) in a canine pacing-induced heart failure model.
  • To assess regional changes in left ventricular (LV) strain using magnetic resonance imaging (MRI).
  • To correlate regional CT-1 levels with regional LV strain and remodeling.

Main Methods:

  • Dilated cardiomyopathy was induced in dogs via rapid ventricular pacing.
  • Regional myocardial CT-1 levels were measured from biopsies of different LV walls.
  • Tissue-tagged MRI was used to quantify regional LV strain, specifically minimal principal strain (MPS).

Main Results:

  • Pacing significantly altered LV ejection fraction and end-diastolic volume.
  • Significant regional differences in CT-1 levels and MPS were observed.
  • CT-1 increased and MPS decreased significantly in the inferior and septal walls, closest to the pacing lead.

Conclusions:

  • The pacing model results in heterogeneous changes in regional CT-1 and wall motion (MPS).
  • The most pronounced changes in CT-1 and MPS occurred in the inferior and septal walls.
  • Regional CT-1 variations may underlie observed myocyte hypertrophy and preserved ventricular function in specific regions.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...